SUMMARY To test the hypothesis that rheumatoid factor (RF) protects against (immune complex mediated) renal disease, patients with rheumatoid arthritis (RA; 48 with nephropathy of various types, 35 without renal disease) and systemic lupus erythematosus (SLE; 35 with and 17 without nephritis) were evaluated for the presence and titre of RF. There was no correlation between RF and nephropathy in RA, whereas in SLE RFs were almost exclusively seen in patients without nephropathy. This result supports the above hypothesis for lupus nephropathy but not for RA associated renal disease, and it may be explained by a more pronounced role for immune complexes in SLE and interference of RFs with the complexes.
perimental in vitro38 and in vivo9 10 studies, have led to a hypothesis that RF protects from immune complex (IC) mediated renal disease (reviewed in Ref. 11) . This hypothesis, also used to explain the relatively rare occurrence of glomerulonephritis (GN) in rheumatoid arthritis, has not been universally accepted. Series of SLE patients have been reported in which there is no such negative correlation between the presence of RF and lupus nephritis.12 13 (the present work) to 53%. 13 A negative correlation such as that in the SLE patients was not found between the presence or titre of RF and any of the renal disease groups in RA patients in our study. Nor was there any positive correlation between renal disease and RF. In this respect RA associated nephropathies seem to differ from such extra-articular RA manifestations as rheumatoid nodules, vasculitis, pulmonary fibrosis, lymphadenopathy, and splenomegaly, which are generally associated with high RF titres.23
In contrast with SLE, there are few data in the literature on the relation between RF and renal disease in RA. Skrifvars et al have suggested that the development of gold nephropathy may be related to an absence of IgM RF in serum.24 In our patients RF negativity was not significantly associated with gold nephropathy: three out of eight patients with an obvious gold nephropathy had a positive RF titre. It is notable, however, that three of the five seronegative patients had earlier been seropositive (Waaler-Rose titres 1/250, 1/250, 1/500). Gold salts have been reported to reduce RF positivity,25 which could result in loss of the protective effect. It is also possible that reduction of RF positivity and gold nephropathy are not causally related but rather two independent sequels of gold therapy. An association has recently been reported between systemic amyloidosis and seronegativity in adult rheumatoid arthritis. 26 In that study RFs were determined by an enzyme immunoassay and the results may not be comparable with ours obtained by a different technique. Half of our patients with amyloidosis had RF titres higher than 1/64.
In our patients RFs were almost exclusively observed in lupus patients without nephropathy, whereas in RA RF positivity was equally common in patients with and without renal disease. This result is compatible with RFs exerting a protective effect against renal disease in SLE but not in RA. This could be explained by different mechanisms producing tissue lesions in these two disorders. The glomerular injury in SLE is regarded as a prototype immune complex lesion. 27 
